Cantor Fitzgerald Maintains Overweight on AvePoint, Lowers Price Target to $18
Benzinga Newsdesk 11 months ago
NewsPrice TargetAnalyst Ratings
Cantor Fitzgerald analyst Thomas Blakey maintains AvePoint (NASDAQ:AVPT) with a Overweight and lowers the price target from $22.5 to $18.
Cantor Fitzgerald analyst Thomas Blakey maintains AvePoint (NASDAQ:AVPT) with a Overweight and lowers the price target from $22.5 to $18.